求購甘油果糖氯化鈉注射液過一評的質(zhì)量信息   [更多]

求購復(fù)方倍他米松注射液標(biāo)準(zhǔn)07詳細(xì)版一份，要包含含量測試方法和條件的。   [更多]

請有資源的在這兒投稿   [更多]

文獻(xiàn)標(biāo)題: 1.Development and evaluation of chitosan based oral controlled matrix tablets of?losartan?potassium J Pharm Investig.?2012 Jul;2(3):157-61. doi: 10.4103/2230-973X.104399. 2.Response criteria of tolvaptan for the treatment of hepatic edema J Gastroenterol. 2017 Jun 29. 3.Hepatol Res.?2017 Oct 6. doi: 10.1111/hepr.12988. [Epub ahead of print] Increased?serum?C-reactive?protein?and?decreased?urinary?aquaporin?2?levels?are?predictive?of the?efficacy?of?tolvaptan?in?patients?with?liver?cirrhosis. 4.Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range. 5.An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles 6.Anatol J Cardiol.?2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan?in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 7.紫外-可見分光光度法測定依達(dá)拉奉注射液中的亞硫酸氫鈉含量 8.Anatol J Cardiol. 2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 備注: 將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

注射用磷酸氟達(dá)拉濱相關(guān)質(zhì)量信息2014要求：清晰易讀   [更多]

1. 如果是單獨(dú)生產(chǎn)批件，可以單品種轉(zhuǎn)讓為宜； MAH制度的省市合作信息亦可。 2. 生產(chǎn)線/藥廠轉(zhuǎn)讓需提供合作模式信息。 3. 需要提供主要負(fù)責(zé)人的職位及手機(jī)號，以便驗(yàn)證信息的真實(shí)和可靠性。 4. 藥智數(shù)據(jù)信息收錄的除外。 5. 提供信息以公司名稱計(jì)，給予100元的信息獎(jiǎng)勵(lì)   [更多]

克感額日敦片信息，PDF格式或照片均可，必須是原文掃描件或照片，不能是自己編制的word等版本   [更多]

求購熊去氧膽酸、?；切苋パ跄懰崮z囊注冊標(biāo)準(zhǔn)；都需要最新的標(biāo)準(zhǔn)   [更多]

要求如下：為標(biāo)準(zhǔn)版產(chǎn)品備案資料，可以順利過審（廣東深圳）的資料，具體需求資料如下，缺一不可： 1、備案表 2、產(chǎn)品安全風(fēng)險(xiǎn)分析報(bào)告 3、產(chǎn)品技術(shù)要求 4、產(chǎn)品檢驗(yàn)報(bào)告 5、臨床評價(jià)資料 6 、產(chǎn)品說明書及最小銷售單元標(biāo)簽設(shè)計(jì)樣稿 7、生產(chǎn)制造信息 8、符合性聲明 9、工藝流程圖 10、主要生產(chǎn)和檢測設(shè)備清單 11、產(chǎn)品有效成分、有效成分占比及有效成分的作用   [更多]

標(biāo)題： 1、Comparative Pharmacokinetics of the New Oral Cephalosporins 2、Jiang X, Wang N, Zhang Z J, et al. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.[J]. Arzneimittel-Forschung, 2008, 58(7):363-366. 3、Almeida S, Filipe A, Vallée F, et al. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers.[J]. Arzneimittel-Forschung, 2004, 54(11):757-62. 4、De-Oliveira C, Barrientos-Astigarraga R, De-Moraes M, et al. Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study.[J]. Therapeutic Drug Monitoring, 2001, 23(6):709. 5、Impact of moisture and magnesium stearate functionality on manufacturability of wet granulated metformin tablets 6、The?antipruritic?effect?of?5%?doxepin?cream?in?patients?with?eczematousdermatitis.?Doxepin?Study Group. 7、Photoisomerization of Ionic Liquid Ammonium Cinnamates: One-Pot Synthesis?Isolation of Z-Cinnamic Acids 8、[Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. 9、Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study 10、Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies 備注：將符合的文獻(xiàn)PDF格式打包上傳   [更多]